Pharming Group N.V. - ADR

-0.06 (-0.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)777.82M
Current PE25.61
Forward PE 27.14
2yr Forward PE 42.64
See more stats
Estimates Current Quarter
Revenue$57.94 Million
Adjusted EPS$0.06
See more estimates
10-Day MA$12.29
50-Day MA$10.88
200-Day MA$9.46
See more pivots

Pharming Group N.V. - ADR Stock, NASDAQ:PHAR

Darwinweg 24, Leiden, Zuid-Holland 2332 CR
Phone: +31.71.524.74.00
Number of Employees:


Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.